{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T16:49:25Z","timestamp":1761929365487},"reference-count":34,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2007,11,28]],"date-time":"2007-11-28T00:00:00Z","timestamp":1196208000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0000034","type":"journal-article","created":{"date-parts":[[2007,11,27]],"date-time":"2007-11-27T23:14:24Z","timestamp":1196205264000},"page":"e34","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":43,"title":["Optimization of Topical Therapy for Leishmania major Localized Cutaneous Leishmaniasis Using a Reliable C57BL\/6 Model"],"prefix":"10.1371","volume":"1","author":[{"given":"Herv\u00e9","family":"Lecoeur","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Buffet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gloria","family":"Morizot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie","family":"Goyard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ghislaine","family":"Guigon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Genevi\u00e8ve","family":"Milon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thierry","family":"Lang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2007,11,28]]},"reference":[{"key":"ref1","first-page":"77","article-title":"Worldwide increasing risk factors for leishmaniasis.","volume":"190","author":"P Desjeux","year":"2001","journal-title":"Medical Microbiology&Immunology"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.pt.2006.09.004","article-title":"Leishmaniasis and poverty.","volume":"22","author":"J Alvar","year":"2006","journal-title":"Trends in Parasitology"},{"key":"ref3","first-page":"383","article-title":"Cutaneous leishmaniasis in France: towards the end of injectable therapy?","volume":"96","author":"P Buffet","year":"2003","journal-title":"Bull Soc Pathol Exot"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.idc.2004.11.005","article-title":"Cutaneous leishmaniasis in the returning traveler.","volume":"19","author":"AJ Magill","year":"2005","journal-title":"Infect Dis Clin North Am"},{"key":"ref5","first-page":"847","article-title":"Therapy in man.","author":"A Bryceson","year":"1987"},{"key":"ref6","first-page":"538","article-title":"Topical treatment for cutaneous leishmaniasis.","volume":"3","author":"T Garnier","year":"2002","journal-title":"Current opinion in investigational drugs"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1179\/000349803225001373","article-title":"The efficacy of treatment with intralesional meglumine antimoniate alone, compared with that of cryotherapy combined with the meglumine antimoniate or intralesional sodium stibogluconate, in the treatment of cutaneous leishmaniasis.","volume":"97","author":"A Asilian","year":"2003","journal-title":"Ann Trop Med Parasitol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/1523-1747.ep12696697","article-title":"Topical treatment of cutaneous leishmaniasis.","volume":"87","author":"J El-On","year":"1986","journal-title":"J Invest Dermatol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0190-9622(92)70175-F","article-title":"Topical treatment of Old World cutaneous leishmaniasis caused by Leishmania major: a double-blind control study.","volume":"27","author":"J El-On","year":"1992","journal-title":"J Am Acad Dermatol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/0035-9203(90)90146-6","article-title":"A double-blind clinical trial of the treatment of cutaneous leishmaniasis with paromomycin ointment.","volume":"84","author":"SH el-Safi","year":"1990","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/0035-9203(94)90308-5","article-title":"Treatment of Old-World Cutaneous Leishmaniasis with Aminosidine Ointment-Results of an Open Study in London.","volume":"88","author":"ADM Bryceson","year":"1994","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"648","DOI":"10.4269\/ajtmh.1995.53.648","article-title":"A randomized, placebo-controlled trial of a two-week regimen of aminosidine (paromomycin) ointment for treatment of cutaneous leishmaniasis in Iran.","volume":"53","author":"A Asilian","year":"1995","journal-title":"Am J Trop Med Hyg"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"162","DOI":"10.4269\/ajtmh.1995.53.162","article-title":"A randomized, placebo-controlled trial in Tunisia treating cutaneous leishmaniasis with paromomycin ointment.","volume":"53","author":"A Ben Salah","year":"1995","journal-title":"Am J Trop Med Hyg"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"147","DOI":"10.4269\/ajtmh.2002.66.147","article-title":"Treatment of cutaneous leishmaniasis with a topical antileishmanial drug (WR279396): Phase 2 pilot study.","volume":"66","author":"JM Soto","year":"2002","journal-title":"Am J Trop Med Hyg"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1046\/j.1365-2133.1998.02554.x","article-title":"The novel ascomycin derivative SDZ ASM 981 is effective for psoriasis when used topically under occlusion.","volume":"139","author":"U Mrowietz","year":"1998","journal-title":"Br J Dermatol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1179\/136485905X16372","article-title":"Efficacy of paromomycin ointment in the treatment of cutaneous leishmaniasis: results of a double-blind, randomized trial in Isfahan, Iran.","volume":"99","author":"F Iraji","year":"2005","journal-title":"Ann Trop Med Parasitol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/0035-9203(94)90517-7","article-title":"Topical treatment of American cutaneous leishmaniasis with paramomycin and methylbenzethonium chloride: a clinical study under field conditions in Ecuador.","volume":"88","author":"G Krause","year":"1994","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"969","DOI":"10.4049\/jimmunol.165.2.969","article-title":"A natural model of <italic>Leishmania major<\/italic> infection reveals a prolonged \u201csilent\u201d phase of parasite amplification in the skin before the onset of lesion formation and immunity.","volume":"165","author":"Y Belkaid","year":"2000","journal-title":"J Immunol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/0035-9203(86)90176-8","article-title":"Failure of Meglumine Antimoniate to Cure Cutaneous Lesions Due to Leishmania-Major in Algeria.","volume":"80","author":"S Belazzoug","year":"1986","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1462-5822.2004.00468.x","article-title":"Bioluminescent <italic>Leishmania<\/italic> expressing luciferase for rapid and high throughput of drugs acting on amastigote-harbouring macrophages and for quantitative real-time monitoring of parasitism features in living mice.","volume":"7","author":"T Lang","year":"2005","journal-title":"Cellular Microbiology"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0166-6851(03)00142-7","article-title":"An in vitro system for developmental and genetic studies of <italic>Leishmania donovani<\/italic> phosphoglycans.","volume":"130","author":"S Goyard","year":"2003","journal-title":"Mol Biochem Parasitol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1006\/expr.2001.4656","article-title":"A lipophosphoglycan-independent method for isolation of infective Leishmania metacyclic promastigotes by density gradient centrifugation.","volume":"99","author":"GF Sp\u00e4th","year":"2001","journal-title":"Exp Parasitol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"354","DOI":"10.2307\/3285646","article-title":"Successful topical treatment of murine cutaneous leishmaniasis with a combination of paromomycin (Aminosidine) and gentamicin.","volume":"85","author":"M Grogl","year":"1999","journal-title":"J Parasitol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"4537","DOI":"10.4049\/jimmunol.157.10.4537","article-title":"The outcome of the parasitic process initiated by <italic>Leishmania infantum<\/italic> in laboratory mice: a tissue-dependent pattern controlled by the <italic>Lsh<\/italic> and MHC loci.","volume":"157","author":"V Leclercq","year":"1996","journal-title":"J Immunol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"4891","DOI":"10.4049\/jimmunol.151.9.4891","article-title":"Resistance of mice to experimental leishmaniasis is associated with more rapid appearance of mature macrophages in vitro and in vivo.","volume":"151","author":"C Sunderkotter","year":"1993","journal-title":"J Immunol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0022-1759(87)90115-3","article-title":"Limiting dilution assays. Experimental design and statistical analysis.","volume":"97","author":"LW Strijbosch","year":"1987","journal-title":"J Immunol Methods"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.4049\/jimmunol.126.4.1614","article-title":"Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis.","volume":"126","author":"C Taswell","year":"1981","journal-title":"J Immunol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/00000441-199207000-00007","article-title":"Effect of Occlusive Dressings on the Stratum-Corneum Water Holding Capacity.","volume":"304","author":"E Berardesca","year":"1992","journal-title":"Am J Med Sci"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0140-6736(05)62161-7","article-title":"Occlusive paromomycin for cutaneous leishmaniasis [see comments].","volume":"349","author":"SA Bell","year":"1997","journal-title":"Lancet"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1001\/archderm.1993.01680250126022","article-title":"Cutaneous Leishmaniasis Treated with Controlled Localized Heating.","volume":"129","author":"JH Saurat","year":"1993","journal-title":"Arch Dermatol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/00001432-200310000-00005","article-title":"Current treatment approaches to leishmaniasis.","volume":"16","author":"J Berman","year":"2003","journal-title":"Current Opinion in Infectious Diseases"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/0006-2952(78)90370-2","article-title":"Uptake and Intracellular Accumulation of Aminoglycoside Antibiotics in Lysosomes of Cultured Rat Fibroblasts.","volume":"27","author":"P Tulkens","year":"1978","journal-title":"Biochem Pharmacol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/BF01964420","article-title":"Intracellular-Distribution and Activity of Antibiotics.","volume":"10","author":"PM Tulkens","year":"1991","journal-title":"European Journal of Clinical Microbiology&Infectious Diseases"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"6561","DOI":"10.1128\/IAI.68.12.6561-6566.2000","article-title":"<italic>Leishmania major<\/italic> reaches distant cutaneous sites where it persists transiently while persisting durably in the primary dermal site and its draining lymph node: a study with laboratory mice.","volume":"68","author":"L Nicolas","year":"2000","journal-title":"Infect Immun"}],"container-title":["PLoS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pntd.0000034","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T00:11:11Z","timestamp":1684109471000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0000034"}},"subtitle":[],"editor":[{"given":"Charles","family":"Jaffe","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2007,11,28]]},"references-count":34,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2007,11,28]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0000034","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,11,28]]}}}